Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
NUP214-ABL1 fusion
i
Other names:
NUP214, Nucleoporin 214, Nuclear Pore Complex Protein Nup214, CAN Protein, Putative Oncogene, Nucleoporin 214kDa, CAIN, Nucleoporin 214kD (CAIN), 214 KDa Nucleoporin, Nucleoporin Nup214, Protein CAN, IIAE9, ABL proto-oncogene 1, ABL, c-ABL, JTK7, p150, ABL1
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
25
;
8021
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
ABL1 expression (1)
ABL1 expression (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
NUP214-ABL1 fusion
B Acute Lymphoblastic Leukemia
NUP214-ABL1 fusion
B Acute Lymphoblastic Leukemia
ponatinib + blinatumomab
Sensitive: C4 – Case Studies
ponatinib + blinatumomab
Sensitive
:
C4
ponatinib + blinatumomab
Sensitive: C4 – Case Studies
ponatinib + blinatumomab
Sensitive
:
C4
NUP214-ABL1 fusion
Acute Lymphocytic Leukemia
NUP214-ABL1 fusion
Acute Lymphocytic Leukemia
YD312
Sensitive: D – Preclinical
YD312
Sensitive
:
D
YD312
Sensitive: D – Preclinical
YD312
Sensitive
:
D
NUP214-ABL1 fusion
Acute Lymphocytic Leukemia
NUP214-ABL1 fusion
Acute Lymphocytic Leukemia
asciminib
Sensitive: D – Preclinical
asciminib
Sensitive
:
D
asciminib
Sensitive: D – Preclinical
asciminib
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.